UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 509

Sortiert nach

Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Clinical microbiology reviews, 2018-04, Vol.31 (2)

2018

Link zum Volltext

Verfügbarkeit prüfen

Short Antimicrobial Peptides and Peptide Scaffolds as Promising Antibacterial Agents

Current topics in medicinal chemistry, 2016-05, Vol.16 (11), p.1217

2016

Link zum Volltext

Verfügbarkeit prüfen

Cationic Amphiphiles, a New Generation of Antimicrobials Inspired by the Natural Antimicrobial Peptide Scaffold

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4049-4058

2010

Link zum Volltext

Verfügbarkeit prüfen

Microbiology and Preclinical Review of Omadacycline

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S6-S15

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of MRSA in Canada from 2007 to 2016

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (Suppl 4), p.iv55-iv63

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (Suppl 4), p.iv39-iv47

2019

Link zum Volltext

Verfügbarkeit prüfen

Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance

Clinical infectious diseases, 2015-09, Vol.61 (suppl 2), p.S58-S68

2015

Link zum Volltext

Verfügbarkeit prüfen

Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (Suppl 4), p.iv48-iv54

2019

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

Journal of antimicrobial chemotherapy, 2013-05, Vol.68 Suppl 1 (suppl 1), p.i7-i22

2013

Link zum Volltext

Verfügbarkeit prüfen

Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria

Journal of medicinal chemistry, 2019-10, Vol.62 (20), p.9103-9115

2019

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Resistance in Hospital-Acquired Gram-Negative Bacterial Infections

Chest, 2015-05, Vol.147 (5), p.1413-1421

2015

Link zum Volltext

Verfügbarkeit prüfen

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

Drugs (New York, N.Y.), 2016-04, Vol.76 (5), p.567-588

2016

Link zum Volltext

Verfügbarkeit prüfen

Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2434-2437

2011

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2554-2563

2014

Link zum Volltext

Verfügbarkeit prüfen

42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (Suppl 4), p.iv5-iv21

2019

Link zum Volltext

Verfügbarkeit prüfen

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada

The Canadian journal of infectious diseases & medical microbiology, 2018-01, Vol.2018, p.8912039-13

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008

Antimicrobial Agents and Chemotherapy, 2009-11, Vol.53 (11), p.4924-4926

2009

Link zum Volltext

Verfügbarkeit prüfen

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

Antimicrobial Agents and Chemotherapy, 2009-07, Vol.53 (7), p.2733-2739

2009

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007 to 2012

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5707-5709

2013

Link zum Volltext

Verfügbarkeit prüfen

Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature

Clinical infectious diseases, 2003-06, Vol.36 (11), p.1404-1410

2003

Link zum Volltext

Verfügbarkeit prüfen

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines

Current opinion in pulmonary medicine, 2010-05, Vol.16 (3), p.217-225

2010

Link zum Volltext

Verfügbarkeit prüfen

Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux

Journal of medicinal chemistry, 2016-09, Vol.59 (18), p.8441-8455

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (Suppl 4), p.iv32-iv38

2019

Link zum Volltext

Verfügbarkeit prüfen

Horizontal transfer of antibiotic resistance from Enterococcus faecium of fermented meat origin to clinical isolates of E. faecium and Enterococcus faecalis

International journal of food microbiology, 2015-04, Vol.199, p.78-85

2015

Link zum Volltext

Verfügbarkeit prüfen

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

The Canadian journal of infectious diseases & medical microbiology, 2018-01, Vol.2018, p.1404813-9

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 509

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(498)
Mit Volltextzugriff
(469)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(371)
Life Sciences & Biomedicine
(363)
Microbiology
(276)
Humans
(270)
Pharmacology & Pharmacy
(241)
Infectious Diseases
(196)
Microbial Sensitivity Tests
(195)
Anti-Bacterial Agents - Pharmacology
(178)
Biological And Medical Sciences
(177)
Medical Sciences
(169)
Pharmacology. Drug Treatments
(145)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(144)
Streptococcus Pneumoniae
(84)
Antibacterial Agents
(80)
Streptococcus Pneumoniae - Drug Effects
(66)
Drug Resistance, Bacterial
(64)
Canada
(60)
Escherichia Coli
(60)
Pseudomonas Aeruginosa
(57)
Anti-Bacterial Agents - Therapeutic Use
(56)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Short Antimicrobial Peptides and Peptide Scaffolds as Promising Antibacterial Agents

Cationic Amphiphiles, a New Generation of Antimicrobials Inspired by the Natural Antimicrobial Peptide Scaffold

Microbiology and Preclinical Review of Omadacycline

Characterization of MRSA in Canada from 2007 to 2016

Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16

Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance

Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria

Antimicrobial Resistance in Hospital-Acquired Gram-Negative Bacterial Infections

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases

In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada

In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

In Vitro Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007 to 2012

Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines

Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux

Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study

Horizontal transfer of antibiotic resistance from Enterococcus faecium of fermented meat origin to clinical isolates of E. faecium and Enterococcus faecalis

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

Suchergebnisse filtern